glp-1 neuropathy Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment GLP-1 | Summary

K., Saharan S., Tripathi M., Murari G

This is particularly true for people who experience limited sun exposure, including people who use cosmetics with UV filters or sunscreen

Additionally, while preclinical studies have demonstrated encouraging results, most research remains in early stages, and the lack of reliable biomarkers for monitoring ferroptosis complicates clinical application

Rare reactions: Severe allergic responses, including anaphylaxis, are extremely uncommon

Additionally, researchers are investigating combination therapies that incorporate GLP-1 receptor agonists with other pharmacological agents

In: Lett JT, Sinclair WK, editors